US Stock MarketDetailed Quotes
GLMD Galmed Pharmaceuticals
- 2.8000
- -0.1600-5.41%
Close Nov 21 16:00 ET
- 2.8000
- 0.00000.00%
Post 20:01 ET
4.22MMarket Cap-667P/E (TTM)
2.9400High2.7500Low45.44KVolume2.9400Open2.9600Pre Close129.59KTurnover3.05%Turnover RatioLossP/E (Static)1.51MShares23.800052wk High0.23P/B4.17MFloat Cap2.730052wk Low--Dividend TTM1.49MShs Float4870.8000Historical High--Div YieldTTM6.42%Amplitude2.7300Historical Low2.8510Avg Price1Lot Size
About Galmed Pharmaceuticals Company
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Company Profile
SymbolGLMD
Company NameGalmed Pharmaceuticals
Listing DateMar 13, 2014
Issue Price13.50
Founded2000
CEOMr. Allen Baharaff
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address16 Abba Hillel Road
CityRamat Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250608
Phone972-3-693-8448
Websitehttp://galmedpharma.com
Company Executives
- Name
- Position
- Salary
- Allen Baharaff
- Director, President and Chief Executive Officer
- 1.36M
- Doron Cohen
- Chief Financial Officer
- 159.66K
- Yohai Stenzler
- Chief Accounting Officer
- 354.14K
- Guy Nehemya
- Chief Operating Officer and Data Protection Officer
- 350.21K
- Dr. Liat Hayardeny
- Chief Scientist Officer
- 239.89K
- Shmuel Nir
- Independent Director
- --
- Dr. David Sidransky, M.D.
- Lead Independent Director
- --
- Amir Poshinski
- Independent Director
- --
- Dr. Carol L. Brosgart, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data